71839-106-24 |
71839-106 |
HUMAN PRESCRIPTION DRUG |
Neostigmine methylsulfate |
Neostigmine methylsulfate |
INJECTION |
INTRAVENOUS |
20190513 |
N/A |
ANDA |
ANDA212512 |
BE Pharmaceuticals Inc. |
NEOSTIGMINE METHYLSULFATE |
1 mg/mL |
24 CARTON in 1 CARTON (71839-106-24) / 1 VIAL, MULTI-DOSE in 1 CARTON (71839-106-01) / 10 mL in 1 VIAL, MULTI-DOSE |
71839-106-10 |
71839-106 |
HUMAN PRESCRIPTION DRUG |
Neostigmine methylsulfate |
Neostigmine methylsulfate |
INJECTION |
INTRAVENOUS |
20220317 |
N/A |
ANDA |
ANDA212512 |
BE Pharmaceuticals Inc. |
NEOSTIGMINE METHYLSULFATE |
1 mg/mL |
10 VIAL, MULTI-DOSE in 1 CARTON (71839-106-10) / 10 mL in 1 VIAL, MULTI-DOSE |
71839-105-24 |
71839-105 |
HUMAN PRESCRIPTION DRUG |
Neostigmine methylsulfate |
Neostigmine methylsulfate |
INJECTION |
INTRAVENOUS |
20190513 |
N/A |
ANDA |
ANDA212512 |
BE Pharmaceuticals Inc. |
NEOSTIGMINE METHYLSULFATE |
.5 mg/mL |
24 CARTON in 1 CARTON (71839-105-24) / 1 VIAL, MULTI-DOSE in 1 CARTON (71839-105-01) / 10 mL in 1 VIAL, MULTI-DOSE |
71839-105-10 |
71839-105 |
HUMAN PRESCRIPTION DRUG |
Neostigmine methylsulfate |
Neostigmine methylsulfate |
INJECTION |
INTRAVENOUS |
20220317 |
N/A |
ANDA |
ANDA212512 |
BE Pharmaceuticals Inc. |
NEOSTIGMINE METHYLSULFATE |
.5 mg/mL |
10 VIAL, MULTI-DOSE in 1 CARTON (71839-105-10) / 10 mL in 1 VIAL, MULTI-DOSE |
31722-994-31 |
31722-994 |
HUMAN PRESCRIPTION DRUG |
neostigmine methylsulfate |
neostigmine methylsulfate |
INJECTION |
INTRAVENOUS |
20210104 |
N/A |
ANDA |
ANDA212512 |
Camber Pharmaceuticals Inc. |
NEOSTIGMINE METHYLSULFATE |
.5 mg/mL |
10 VIAL, MULTI-DOSE in 1 CARTON (31722-994-31) / 10 mL in 1 VIAL, MULTI-DOSE |
31722-995-31 |
31722-995 |
HUMAN PRESCRIPTION DRUG |
neostigmine methylsulfate |
neostigmine methylsulfate |
INJECTION |
INTRAVENOUS |
20210104 |
N/A |
ANDA |
ANDA212512 |
Camber Pharmaceuticals Inc. |
NEOSTIGMINE METHYLSULFATE |
1 mg/mL |
10 VIAL, MULTI-DOSE in 1 CARTON (31722-995-31) / 10 mL in 1 VIAL, MULTI-DOSE |